Piper Sandler Maintains Overweight on CME Gr, Raises Price Target to $258

Benzinga · 5d ago
Piper Sandler analyst Patrick Moley maintains CME Gr (NASDAQ:CME) with a Overweight and raises the price target from $250 to $258.